Total item
Cart Subtotal
$0.00 - Kobayashi T, .et al. A-674563 increases chondrocyte marker expression in cultured chondrocytes by inhibiting Sox9 degradation, Biochem Biophys Res Commun, 2018, Jan 1;495(1):1468-1475 PMID: 29196261
- Lin Xu, .et al. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells, Biochem Biophys Res Commun, 2016, Apr 15;472(4):662-8 PMID: 26920060
- Zou Y, .et al. Pre-clinical assessment of A-674563 as an anti-melanoma agent, Biochem Biophys Res Commun, 2016, Aug 12;477(1):1-8 PMID: 26970307
Biological Activity
A-674563 is a B/Akt inhibitor with an IC50 of 14 nM and also shows inhibitory activity against PKA and CDK2 with IC50 of 16 and 46 nM, respectively.
Targets
| Target | Value |
|---|---|
| Akt1 | ki: 11nM |
| PKA | ki: 16nM |
| CDK2 | ki: 46nM |
| GSK-3β | ki: 110nM |
| ERK2 | ki: 260nM |
| PKCδ | ki: 360nM |
| RSK2 | ki: 580nM |
| MAPK-AP2 | ki: 1.1μM |
| PKCγ | ki: 1.2μM |
| FLT1 | ki: >2.2μM |
| Chk1 | ki: 2.6μM |
| KDR | ki: >3.7μM |
| CK2 | ki: 5.4μM |
| c-Kit | ki: >5.8μM |
| Src | ki: 13μM |
| PDK-1 | ki: >20μM |
| In vitro (25°C) | DMSO | 72 mg/mL (200.87 mM) | |
| Water | 72 mg/mL (200.87 mM) | ||
| Ethanol | 18 mg/mL (50.21 mM) | ||
| In vivo | Saline | 30 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 27.9 mL | 139.51 mL | 279.02 mL |
| 0.5 mM | 5.58 mL | 27.9 mL | 55.8 mL |
| 1 mM | 2.79 mL | 13.95 mL | 27.9 mL |
| 5 mM | 0.56 mL | 2.79 mL | 5.58 mL |
*The above data is based on the productmolecular weight 358.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11034 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 358.4 |
| Formula | C22H22N4O |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 552325-73-2 |
| Synonyms | A674563 |
| SMILES | CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[[email protected]](CC4=CC=CC=C4)N |
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
MK-2206 2HCl
MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively.
TIC10 isomer
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, s…
Triciribine phosphate (NSC-280594)
Triciribine phosphate inhibits the phosphorylation, activation, and signalling of Akt-1, -2, and -3, which may result in the inhibition of A…
GSK2141795 (Uprosertib, GSK795)
Akt inhibitor GSK2141795 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tum…
Deguelin
Deguelin is a natural product that displays profound antiproliferative activity.
CCT128930
CCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over…
AT7867 2HCl
AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, resp…
GDC-0068 (Ipatasertib, RG-7440)
GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in…
Keywords:buy A-674563 | A-674563 Supplier | purchase | cost | manufacturer | order | distributor | buy 552325-73-2| 552325-73-2 Supplier | purchase 552325-73-2 | 552325-73-2 cost | 552325-73-2 manufacturer | order 552325-73-2 | 552325-73-2 distributor
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: [email protected]
Not your Region? View all Distributors
Adooq Quality Guarantee
We promise all products perform as described.